Radiopharm Theranostics Limited Sponsored ADR share price logo

Radiopharm Theranostics Limited Sponsored ADR

NASDAQ: RADX

$0.67

-0.01

(-1.76%)

as on

Radiopharm Theranostics Limited Sponsored ADR Stock Performance

as on November 20, 2026 at 7:59 am IST

  • Day's Low

    Day's High

    $0.63
    $0.70
    downward going graph

    6.39%

    Downside

    4.01%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.63
    $16.25
    downward going graph

    6.11%

    Downside

    2314.56%

    Upside

    downward going graph

Radiopharm Theranostics Limited Sponsored ADR share price movements today

Previous Close
$0.69
Open
$0.68
Volume
810.6K
Market Cap
$10.8M
Day's Low - High
$0.63 - $0.70
52 Week Low - High
$0.63 - $16.25

Radiopharm Theranostics Limited Sponsored ADR Historical Returns

1 Month Return
-32.02 %
3 Month Return
-70.61 %
1 Year Return
-85.01 %
3 Year Return
0 %
5 Year Return
0 %

Radiopharm Theranostics Limited Sponsored ADR Stock Fundamentals & Key Indicators

Check Radiopharm Theranostics Limited Sponsored ADR market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$10.8M

EPS (TTM)

-1404

Dividend Yield

0.00%

PE Ratio (TTM)

-0.26

Industry PE ratio

-4.07

PEG Ratio

-0.00

Return On Equity TTM

-144.24%

Radiopharm Theranostics Limited Sponsored ADR vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Radiopharm Theranostics Limited Sponsored ADR with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
NA$10.8MNA-0.26-39.41%0.00%
Neutral$83.7B-25.40%-29.1428.00%0.00%
StrongBuy$47.2BNA65.7688.39%0.00%
StrongBuy$135.4B193.33%34.1185.53%0.00%
Buy$99.1B44.87%20.2985.77%0.39%

Stock Returns calculator for Radiopharm Theranostics Limited Sponsored ADR Stock including INR - Dollar returns

The Radiopharm Theranostics Limited Sponsored ADR stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Radiopharm Theranostics Limited Sponsored ADR investment value today

Current value as on today

₹15,802

Returns

-₹84,198

(-84.2%)

Returns from Radiopharm Theranostics Limited Sponsored ADR Stock

-₹85,011 (-85.01%)

Dollar Impact

₹813 (+0.81%)

Indian Investors' Interest in Radiopharm Theranostics Limited Sponsored ADR Stock

Search interest for Radiopharm Theranostics Limited Sponsored ADR Stock has decreased by -14% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-14% versus previous 30 day period

Radiopharm Theranostics Limited Sponsored ADR Quarterly Profit & Loss

All numbers in Millions USD

Dec 2024
Jun 2025
Total Revenue
1
1
Gross Profit
-1
0
Operating Income
-30
-39
EBITDA
-29
-39
Interest Expense
0
0
Depreciation
1
-
Income Before Tax
-32
-29
Income Tax Expense
-4
0
Net Income
-26
-28
Net Profit Margin
-90.30%
11.60%

Radiopharm Theranostics Limited Sponsored ADR Annual Profit & Loss

All numbers in Millions USD

Jun 2022
Jun 2023
Jun 2024
Jun 2025
Total Revenue
0
0
3
2
Gross Profit
0
0
0
-2
Operating Income
-34
-36
-38
-66
EBITDA
-31
-44
-
-64
Interest Expense
0
0
0
0
Depreciation
3
3
-
2
Income Before Tax
-34
-47
-38
-55
Income Tax Expense
0
0
0
0
Net Income
-34
-47
-38
-53
Net Profit Margin
100.00%
100.00%
1.08%
-77.67%

Radiopharm Theranostics Limited Sponsored ADR Quarterly Cash Flow

All numbers in Millions USD

Dec 2024
Jun 2025
Net Income
-26
-28
Operating Cash Flow
-22
-32
Investing Cash Flow
-5
0
Financing Cash Flow
32
2
Change in Cash
5
-29

Radiopharm Theranostics Limited Sponsored ADR Annual Cash Flow

All numbers in Millions USD

Jun 2022
Jun 2023
Jun 2024
Jun 2025
Net Income
-34
-47
-
-53
Operating Cash Flow
-23
-22
-36
-51
Investing Cash Flow
-1
0
1
-5
Financing Cash Flow
9
30
45
32
Change in Cash
-15
6
10
-23

Global Institutional Holdings in Radiopharm Theranostics Limited Sponsored ADR

Check out the Institutions with significant holdings in Radiopharm Theranostics Limited Sponsored ADR.

Funds
Holdings
VGI Partners Ltd
0.26%
PNC Financial Services Group Inc
0.13%
SILVERARC CAPITAL MANAGEMENT, LLC
1.59%
UBS Group AG
0.01%
Rhumbline Advisers
0.00%

Radiopharm Theranostics Limited Sponsored ADR News & Key Events

  • img

    Today's Timeline - 16 November

    Mon, 07:09 PM

    -

    Radiopharm presents interim Phase 2b data for RAD101, showing high agreement with MRI and no serious adverse events.

Insights on Radiopharm Theranostics Limited Sponsored ADR

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 780.1% return, outperforming this stock by 864.8%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 months, RADX stock has moved down by -70.1%

About Radiopharm Theranostics Limited Sponsored ADR

Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company develops several products, including RAD101, a pivalate brain metastasis diagnostic; RAD102, a pivalate therapeutic; RAD201a, a Nano-mAb HER-2 breast diagnostic; RAD202, a Nano-mAb HER-2 breast therapeutic; RAD203, a Nano-mAb PDL1 non-small cell lung diagnostic; and RAD204, a Nano-mAb PDL1 non-small cell lung therapeutic. Additionally, it is developing RAD301 and RAD302, which are Avß6-Integrin pancreatic diagnostic and therapeutic products; RAD401, a PSA-mAb prostate cancer diagnostic; RAD402, a PSA-mAb prostate cancer therapeutic; RAD601, a PTPµ glioblastoma diagnostic; and RAD602, a PTPµ glioblastoma therapeutic. The company has a strategic agreement with Lantheus Holdings, Inc. to advance the clinical development of radiopharmaceuticals. The company was incorporated in 2021 and is based in Carlton, Australia.
OrganisationRadiopharm Theranostics Limited Sponsored ADR
Headquarters62 Lygon Street, Carlton, VIC, 3053, AU
IndustryBiotechnology
CEORiccardo Canevari

Key Management of Radiopharm Theranostics Limited Sponsored ADR

Name

Title

Mr. Aaron Laurita

Chief Financial Officer

Mr. Hitesh Goel

Head of Project Management

Mr. Nathan Jong C.A.

Joint Company Secretary

Ms. Amritha Sushil

Joint Company Secretary

Mr. Paul Edward-Alexander Hopper A.S.i.A, B.A (UNSW), FAICD

Founder & Executive Chairman

Mr. Riccardo Canevari

MD, CEO & Director

Dr. Dimitris Voliotis M.D.

Chief Medical Officer

FAQs

What is Radiopharm Theranostics Limited Sponsored ADR share price today?

Radiopharm Theranostics Limited Sponsored ADR share price today is $0.67 as on at the close of the market. Radiopharm Theranostics Limited Sponsored ADR share today touched a day high of $0.70 and a low of $0.63.

What is the 52 week high and 52 week low for Radiopharm Theranostics Limited Sponsored ADR share?

Radiopharm Theranostics Limited Sponsored ADR share touched a 52 week high of $16.25 on and a 52 week low of $0.63 on . Radiopharm Theranostics Limited Sponsored ADR stock price today i.e. is closed at $0.67,which is 95.86% down from its 52 week high and 6.50% up from its 52 week low.

What is Radiopharm Theranostics Limited Sponsored ADR's market capitalisation today?

Radiopharm Theranostics Limited Sponsored ADR market capitalisation is $0.00T as on .

How to invest in Radiopharm Theranostics Limited Sponsored ADR Stock (RADX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Radiopharm Theranostics Limited Sponsored ADR on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Radiopharm Theranostics Limited Sponsored ADR Stock (RADX) from India?

Indian investors can start investing in Radiopharm Theranostics Limited Sponsored ADR (RADX) shares with as little as ₹93.29000091552734 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹932.90 in Radiopharm Theranostics Limited Sponsored ADR stock (as per the Rupee-Dollar exchange rate as on ). Based on Radiopharm Theranostics Limited Sponsored ADR share’s latest price of $0.67 as on November 20, 2026 at 2:29 am IST, you will get 14.8588 shares of Radiopharm Theranostics Limited Sponsored ADR. Learn more about fractional shares .